Long-Term Clinical Outcomes After Drug-Eluting and Bare-Metal Stenting in Massachusetts

Abstract

DES treatment was associated with lower rates of mortality, myocardial infarction, and target-vessel revascularization than BMS treatment in similar patients in a matched population-based study. Comprehensive follow-up in this inclusive population is warranted to identify whether similar safety and efficacy remain beyond 2 years.